KETA.CN TripSitter Clinic (CNQ) down 61.76% on 24 Mar 2026: key risk ahead

KETA.CN stock fell sharply during market hours on 24 Mar 2026, trading at C$0.065 after a -61.76% intraday move on high volume. TripSitter Clinic Ltd. (KETA.CN) on the CNQ saw 64,500 shares trade versus a 6,800 average, signaling forced selling or a block trade. The drop pushed the share price far below the 50-day average of C$0.12 and well under the 200-day average of C$0.08, and it tightened liquidity for small holders. We break down valuation, technicals, Meyka AI grading and the outlook for KETA.CN stock

Intraday move and market detail for KETA.CN stock

The immediate driver was a one-day change of -61.76%, with the stock opening at C$0.09, hitting a low of C$0.06 and closing near C$0.065 on the CNQ in Canada. Volume at 64,500 shares was about 9.49x the average, suggesting outsized selling pressure. The market cap is roughly C$432,781.00, reflecting a very small public float and limited dealer liquidity that amplifies volatility.

Valuation and financials: KETA.CN stock fundamentals

TripSitter Clinic shows negative earnings with EPS of -0.04 and a trailing PE of -1.62, reflecting losses and lack of earnings power. Key ratios show a fragile balance: book value per share is -0.12, current ratio TTM about 0.00, and free cash flow per share -0.01. The company lists revenues per share as 0.00, and working capital is deeply negative, which raises funding and dilution risk for shareholders.

Technical setup and trading signals for KETA.CN stock

Technicals are mixed: RSI is 58.01, CCI is 162.29 (overbought reading prior to the drop) and ATR is 0.03, showing large price swings relative to the low price. The 50-day average is C$0.12 and the 200-day average is C$0.08, both above the current price. On-chain volume indicators show an OBV of -239,187, indicating net outflows. Given the small float, stop-losses and liquidity-driven moves explain the sudden down day.

Meyka AI grade and model forecast for KETA.CN stock

Meyka AI rates KETA.CN with a score out of 100: 63.47 | Grade: B | Suggestion: HOLD. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics and analyst consensus. Meyka AI’s forecast model projects a monthly target of C$0.08 and a quarterly target of C$0.19, versus the current C$0.065. The monthly projection implies a +23.08% move and the quarterly implies +192.31% upside. Forecasts are model-based projections and not guarantees.

Price targets, analyst view and KETA.CN stock outlook

Given volatility and balance sheet risk, we frame price targets as scenario-based: conservative target C$0.05, base case C$0.12, bullish case C$0.35. Those levels use historic highs, moving averages and Meyka AI model outputs. There is no broad sell-side coverage or consensus price target available; company updates and funding news will drive the next leg of movement for KETA.CN stock.

Sector context and key risks for KETA.CN stock

TripSitter Clinic operates in Healthcare, Medical – Healthcare Information Services, a sector under pressure this week with mixed performance. KETA.CN faces regulatory, reimbursement and clinical trial risk plus thin liquidity. Major risks include further dilution, restricted U.S. state-by-state licensing, and weak cash runway. Opportunities hinge on successful commercialization of tele-health ketamine treatment, but execution remains uncertain.

Final Thoughts

KETA.CN stock is a top loser today after a dramatic intraday drop to C$0.065, driven by outsized volume and low market cap dynamics. Fundamentals are weak: EPS -0.04, negative book value per share and negative free cash flow per share point to continued financing risk. Meyka AI rates KETA.CN with a score out of 100 at 63.47 (B, HOLD) — the grade balances strong upside scenarios from model forecasts against severe liquidity and balance-sheet risks. Meyka AI’s forecast model projects C$0.08 in one month (+23.08% vs C$0.065) and C$0.19 in one quarter (+192.31% vs C$0.065). Traders should treat these projections as model-based and not guarantees. For investors, we recommend monitoring near-term corporate announcements, share issuance notices, and any regulatory updates; price target scenarios range from C$0.05 (downside) to C$0.35 (bull case). TripSitter Clinic Ltd. trades on the CNQ in Canada and remains a high-risk, high-volatility security best suited to traders who can handle rapid moves and potential dilution. For company details visit TripSitter Clinic and for filings or profile data consult FinancialModelingPrep. Meyka AI provides this as an AI-powered market analysis platform; this is not financial advice.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.